Science News
from research organizations
Targeting sugars in quest for vaccine against HIV - the virus that causes AIDS
- Date:
- August 21, 2012
- Source:
- American Chemical Society (ACS)
- Summary:
- As a step toward designing the first effective anti-HIV vaccine, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV, the virus that causes AIDS, and neutralize it — stop it from infecting human cells. They recently described the antibodies, which were isolated from people infected with HIV and can neutralize a wide range of HIV strains.
- Share:
FULL STORY
As a step toward designing the first effective vaccine against HIV, the virus that causes AIDS, scientists are reporting new insights into how a family of rare, highly potent antibodies bind to HIV and neutralize it -- stop it from infecting human cells. The antibodies were isolated from people infected with HIV and work against a wide range of HIV strains. The researchers described the study August 21 at the 244th National Meeting & Exposition of the American Chemical Society.
Story Source:
Materials provided by American Chemical Society (ACS). Note: Content may be edited for style and length.
Cite This Page:
American Chemical Society (ACS). "Targeting sugars in quest for vaccine against HIV - the virus that causes AIDS." ScienceDaily. ScienceDaily, 21 August 2012. <www.sciencedaily.com
American Chemical Society (ACS). (2012, August 21). Targeting sugars in quest for vaccine against HIV - the virus that causes AIDS. ScienceDaily. Retrieved October 9, 2025 from www.sciencedaily.com
American Chemical Society (ACS). "Targeting sugars in quest for vaccine against HIV - the virus that causes AIDS." ScienceDaily. www.sciencedaily.com
Explore More
from ScienceDaily
RELATED STORIES